https://www.cnn.com/2022/02/11/health/lilly-monoclonal-antibody-covid-omicron-fda-authorization/index.html
The US Food and Drug Administration has authorized a new monoclonal antibody treatment that seems to work against the Omicron variant of the virus that causes Covid-19.
Create an account or login to join the discussion